Anti-NEK6 monoclonal antibody

Pre-made anti-NEK6 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to NEK6/NEK6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T78992-Ab-1/ GM-Tg-hg-T78992-Ab-2Anti-Human NEK6 monoclonal antibodyHuman
GM-Tg-rg-T78992-Ab-1/ GM-Tg-rg-T78992-Ab-2Anti-Rat NEK6 monoclonal antibodyRat
GM-Tg-mg-T78992-Ab-1/ GM-Tg-mg-T78992-Ab-2Anti-Mouse NEK6 monoclonal antibodyMouse
GM-Tg-cynog-T78992-Ab-1/ GM-Tg-cynog-T78992-Ab-2Anti-Cynomolgus/ Rhesus macaque NEK6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T78992-Ab-1/ GM-Tg-felg-T78992-Ab-2Anti-Feline NEK6 monoclonal antibodyFeline
GM-Tg-cang-T78992-Ab-1/ GM-Tg-cang-T78992-Ab-2Anti-Canine NEK6 monoclonal antibodyCanine
GM-Tg-bovg-T78992-Ab-1/ GM-Tg-bovg-T78992-Ab-2Anti-Bovine NEK6 monoclonal antibodyBovine
GM-Tg-equg-T78992-Ab-1/ GM-Tg-equg-T78992-Ab-2Anti-Equine NEK6 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T78992-Ab-1/ GM-Tg-hg-T78992-Ab-2; GM-Tg-rg-T78992-Ab-1/ GM-Tg-rg-T78992-Ab-2;
GM-Tg-mg-T78992-Ab-1/ GM-Tg-mg-T78992-Ab-2; GM-Tg-cynog-T78992-Ab-1/ GM-Tg-cynog-T78992-Ab-2;
GM-Tg-felg-T78992-Ab-1/ GM-Tg-felg-T78992-Ab-2; GM-Tg-cang-T78992-Ab-1/ GM-Tg-cang-T78992-Ab-2;
GM-Tg-bovg-T78992-Ab-1/ GM-Tg-bovg-T78992-Ab-2; GM-Tg-equg-T78992-Ab-1/ GM-Tg-equg-T78992-Ab-2
Products NameAnti-NEK6 monoclonal antibody
Formatmab
Target NameNEK6
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-NEK6 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T78992-Ag-1Recombinant multi-species NEK6/ SID6-1512 protein


    Target information

    Target IDGM-T78992
    Target NameNEK6
    Gene ID10783,59126,360161,100427402,609003,101080747,515816,100071002
    Gene Symbol and Synonyms1300007C09Rik,NEK6,SID6-1512
    Uniprot AccessionQ9HC98,P59895
    Uniprot Entry NameNEK6_HUMAN,NEK6_RAT
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000119408
    Target ClassificationKinase

    The target: NEK6, gene name: NEK6, also named as SID6-1512. The protein encoded by this gene is a kinase required for progression through the metaphase portion of mitosis. Inhibition of the encoded protein can lead to apoptosis. This protein also can enhance tumorigenesis by suppressing tumor cell senescence. Several transcript variants encoding a few different isoforms have been found for this gene. [provided by RefSeq, Oct 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.